October 16, 2024 17:00 Non Regulatory Flerie AB’s Nomination Committee for the 2025 Annual General Meeting
October 11, 2024 08:00 Non Regulatory Invitation to presentation and Q&A of Flerie’s Q3 2024 interim report
July 29, 2024 12:42 Non Regulatory Flerie increases its shareholding in Xspray Pharma and comments on FDA feedback on Dasynoc
July 12, 2024 08:00 Non Regulatory Invitation to presentation and Q&A of Flerie’s Q2 2024 interim report
March 1, 2024 Flerie Invest AB has increased its holding in Lipum AB (publ), whereby the limit for mandatory bidding has been exceeded
February 6, 2023 09:40 Non Regulatory Flerie appoints seasoned industry experts to its Board of Directors
October 15, 2021 07:00 Non Regulatory Flerie Invest AB leads $52m acquisition of Swedish Biopharma Facility from Charles River